Citadel Advisors
TRIB

Citadel Advisors’s Trinity Biotech TRIB Stock Holding History

Citadel Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.7K Sell
14,200
-12,100
-46% -$8.9K ﹤0.01% 12786
2025
Q4 		$20.8K Buy
+26,300
New +$25.9K ﹤0.01% 12337
2025
Q3 		– Sell
-13,300
Closed -$8.82K – 14136
2025
Q2 		$8.82K Sell
13,300
-13,400
-50% -$8.96K ﹤0.01% 12204
2025
Q1 		$15.2K Buy
+26,700
New +$21.1K ﹤0.01% 13330
2024
Q3 		– Sell
-2,160
Closed -$4.47K – 15269
2024
Q2 		$4.47K Buy
+2,160
New +$4.19K ﹤0.01% 13479
2024
Q1 		– Sell
-200
Closed -$429 – 15445
2023
Q4 		$429 Buy
+200
New +$477 ﹤0.01% 14030
2023
Q3 		– Sell
-860
Closed -$4.15K – 15120
2023
Q2 		$4.15K Sell
860
-300
-26% -$1.45K ﹤0.01% 13628
2023
Q1 		$5.45K Buy
+1,160
New +$5.98K ﹤0.01% 13871
2022
Q2 		– Sell
-3,480
Closed -$18K – 14117
2022
Q1 		$18K Sell
3,480
-340
-9% -$1.96K ﹤0.01% 13277
2021
Q4 		$27K Sell
3,820
-380
-9% -$3.59K ﹤0.01% 13510
2021
Q3 		$45K Sell
4,200
-5,720
-58% -$67.1K ﹤0.01% 13423
2021
Q2 		$146K Buy
9,920
+5,440
+121% +$90.5K ﹤0.01% 12533
2021
Q1 		$84K Buy
4,480
+1,060
+31% +$25.5K ﹤0.01% 12609
2020
Q4 		$65K Sell
3,420
-1,220
-26% -$20.2K ﹤0.01% 10463
2020
Q3 		$47K Buy
4,640
+800
+21% +$9.26K ﹤0.01% 9625
2020
Q2 		$42K Buy
+3,840
New +$29.3K ﹤0.01% 9381

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's TRIB Position: Q4 2025 in Review

Citadel Advisors sold out of Trinity Biotech (TRIB) in Q4 2025, closing a stake of 39,384 shares — an estimated $38.7K sold.

Citadel Advisors first reported a position in TRIB in Q4 2013 and held it in 21 quarters. The position peaked at $892K in Q1 2015. 27 funds tracked by Wall St. Rank hold TRIB as of Q4 2025.

  • Citadel Advisors reported no remaining Trinity Biotech position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 39,384 Trinity Biotech shares in Q4 2025, an estimated $38.7K.
  • Citadel Advisors first reported a position in Trinity Biotech in Q4 2013 and held it in 21 quarters.
  • Citadel Advisors's Trinity Biotech position peaked at $892K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.